BNP Paribas Financial Markets’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $835K | Buy |
242,610
+168,448
| +227% | +$579K | ﹤0.01% | 2304 |
|
2025
Q1 | $158K | Buy |
74,162
+23,068
| +45% | +$49.1K | ﹤0.01% | 3012 |
|
2024
Q4 | $163K | Buy |
51,094
+3,529
| +7% | +$11.3K | ﹤0.01% | 3130 |
|
2024
Q3 | $635K | Buy |
47,565
+44,174
| +1,303% | +$590K | ﹤0.01% | 2053 |
|
2024
Q2 | $33.8K | Buy |
3,391
+3,387
| +84,675% | +$33.8K | ﹤0.01% | 2871 |
|
2024
Q1 | $45 | Hold |
4
| – | – | ﹤0.01% | 3314 |
|
2023
Q4 | $15 | Hold |
4
| – | – | ﹤0.01% | 3264 |
|
2023
Q3 | $10 | Hold |
4
| – | – | ﹤0.01% | 3207 |
|
2023
Q2 | $25 | Sell |
4
-12
| -75% | -$75 | ﹤0.01% | 3262 |
|
2023
Q1 | $101 | Buy |
+16
| New | +$101 | ﹤0.01% | 3145 |
|
2014
Q3 | – | Sell |
-167
| Closed | -$5.2K | – | 3552 |
|
2014
Q2 | $5.2K | Hold |
167
| – | – | ﹤0.01% | 2102 |
|
2014
Q1 | $4.02K | Hold |
167
| – | – | ﹤0.01% | 2035 |
|
2013
Q4 | $834 | Buy |
+167
| New | +$834 | ﹤0.01% | 3331 |
|